- Home
- ATAI vs INFU Comparison
ATAI vs INFU Comparison
Compare ATAI & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- INFU
- Stock Information
- Founded
- ATAI 2018
- INFU 2005
- Country
- ATAI Germany
- INFU United States
- Employees
- ATAI N/A
- INFU N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- INFU Medical/Dental Instruments
- Sector
- ATAI Health Care
- INFU Health Care
- Exchange
- ATAI Nasdaq
- INFU Nasdaq
- Market Cap
- ATAI 222.3M
- INFU 189.2M
- IPO Year
- ATAI 2021
- INFU N/A
- Fundamental
- Price
- ATAI $1.50
- INFU $8.23
- Analyst Decision
- ATAI Strong Buy
- INFU
- Analyst Count
- ATAI 4
- INFU 0
- Target Price
- ATAI $9.00
- INFU N/A
- AVG Volume (30 Days)
- ATAI 1.9M
- INFU 65.5K
- Earning Date
- ATAI 11-13-2024
- INFU 03-13-2025
- Dividend Yield
- ATAI N/A
- INFU N/A
- EPS Growth
- ATAI N/A
- INFU 60.96
- EPS
- ATAI N/A
- INFU 0.07
- Revenue
- ATAI $331,000.00
- INFU $132,783,999.00
- Revenue This Year
- ATAI $80.07
- INFU $10.23
- Revenue Next Year
- ATAI N/A
- INFU $8.80
- P/E Ratio
- ATAI N/A
- INFU $117.93
- Revenue Growth
- ATAI N/A
- INFU 8.17
- 52 Week Low
- ATAI $1.03
- INFU $5.74
- 52 Week High
- ATAI $2.85
- INFU $10.03
- Technical
- Relative Strength Index (RSI)
- ATAI 52.34
- INFU 50.71
- Support Level
- ATAI $1.36
- INFU $7.86
- Resistance Level
- ATAI $1.50
- INFU $8.15
- Average True Range (ATR)
- ATAI 0.15
- INFU 0.35
- MACD
- ATAI -0.00
- INFU 0.01
- Stochastic Oscillator
- ATAI 41.43
- INFU 58.70
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.